- Home
- STRO vs FLL Comparison
STRO vs FLL Comparison
Compare STRO & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FLL
- Stock Information
- Founded
- STRO 2003
- FLL 1987
- Country
- STRO United States
- FLL United States
- Employees
- STRO N/A
- FLL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FLL Hotels/Resorts
- Sector
- STRO Health Care
- FLL Consumer Discretionary
- Exchange
- STRO Nasdaq
- FLL Nasdaq
- Market Cap
- STRO 94.9M
- FLL 108.7M
- IPO Year
- STRO 2018
- FLL 1993
- Fundamental
- Price
- STRO $0.89
- FLL $2.63
- Analyst Decision
- STRO Hold
- FLL Buy
- Analyst Count
- STRO 7
- FLL 4
- Target Price
- STRO $1.97
- FLL $5.00
- AVG Volume (30 Days)
- STRO 782.2K
- FLL 195.1K
- Earning Date
- STRO 11-06-2025
- FLL 11-06-2025
- Dividend Yield
- STRO N/A
- FLL N/A
- EPS Growth
- STRO N/A
- FLL N/A
- EPS
- STRO N/A
- FLL N/A
- Revenue
- STRO $105,646,000.00
- FLL $299,916,000.00
- Revenue This Year
- STRO $65.48
- FLL $4.96
- Revenue Next Year
- STRO N/A
- FLL $8.15
- P/E Ratio
- STRO N/A
- FLL N/A
- Revenue Growth
- STRO N/A
- FLL 7.45
- 52 Week Low
- STRO $0.52
- FLL $2.25
- 52 Week High
- STRO $3.01
- FLL $5.59
- Technical
- Relative Strength Index (RSI)
- STRO 48.24
- FLL 53.79
- Support Level
- STRO $0.81
- FLL $2.25
- Resistance Level
- STRO $0.95
- FLL $2.74
- Average True Range (ATR)
- STRO 0.08
- FLL 0.18
- MACD
- STRO -0.00
- FLL 0.04
- Stochastic Oscillator
- STRO 53.02
- FLL 75.70
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.